Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enrichment of Elevated Plasma F2t-Isoprostane Levels in Individuals with Autism Who Are Stratified by Presence of Gastrointestinal Dysfunction

3 Jul 2013

Abstract excerpt

Etiology is unknown in the majority of individuals with autism spectrum disorder (ASD). One strategy to investigate pathogenesis is to stratify this heterogeneous disorder based on a prominent phenotypic feature that enriches for homogeneity within population strata. Co-occurring gastrointestinal dysfunction (GID) characterizes a subset of children with ASD. Our current objective was to investigate a potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autism Spectrum Disorder Research
Share to Child Nutrition and Feeding Issues
Share to Genetics and Neurodevelopmental Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23844202
DOI: 10.1371/journal.pone.0068444

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enrichment of Elevated Plasma F2t-Isoprostane Levels in Individuals with Autism Who Are Stratified by Presence of Gastrointestinal DysfunctionPMID 23844202Read ↗

Autism spectrum disorder: pathogenesis, biomarker, and intervention therapySemantic proximity Read ↗

Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiomeSemantic proximity Read ↗

Clinical Profiles in Autism Spectrum Disorder: Enhancing Diagnosis, Treatment, and Overall Health OutcomesSemantic proximity Read ↗

Phenotypically driven subgroups of ASD display distinct metabolomic profiles.Semantic proximity Read ↗

Metabolic and Inflammatory Dysregulation in Autism Spectrum Disorder and COVID-19: A Hypothesis-Generating ReviewSemantic proximity Read ↗

Alterations in Gut Vitamins and Amino Acids Metabolism are Associated with Symptoms and Neurodevelopment of Children with Autism Spectrum DisordersSemantic proximity Read ↗

A study of genetic heterogeneity in autism spectrum disorders based on plasma proteomic and metabolomic analysis: multiomics study of autism heterogeneitySemantic proximity Read ↗

Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.Semantic proximity Read ↗

The early life exposome and autism risk: a role for the maternal microbiome?Semantic proximity Read ↗

Metabolomics: Perspectives on Clinical Employment in Autism Spectrum Disorder.Semantic proximity Read ↗

Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disordersSemantic proximity Read ↗

Biochemical, Genetic and Clinical Diagnostic Approaches to Autism-Associated Inherited Metabolic DisordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.